Clinical Trials Logo

Clinical Trial Summary

This study will assess analgesia after robotic lung surgery. Subjects will be randomized to receive wound infiltration and intercostal nerve block with either liposomal bupivacaine or bupivacaine/epinephrine + dexamethasone. Liposomal bupivacaine is a newer local anesthetic product and has not been compared to a combination of bupivacaine/epinephrine + dexamethasone in the context of pain control after robotic lung surgery.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03906617
Study type Interventional
Source The Cooper Health System
Contact Noud van Helmond, MD
Phone 856-968-7336
Email vanhelmond-noud@cooperhealth.edu
Status Recruiting
Phase Phase 4
Start date April 10, 2019
Completion date June 10, 2022